Tobacco manufacturers have recently introduced what the Institute of Medicine describes as potential reduced (tobacco) exposure products (PREPs), including modified cigarettes, novel nicotine delivery devices and oral snuff. These products are promoted with implied and explicit claims of reduced health risk, made without independent scientific validation. Manufacturers have also altered the design of PREPS, potentially in order to enhance consumer acceptability, contribute to dependence, and alter consumer perceptions of PREP """"""""safety."""""""" Despite the lack of research to support PREP health claims, PREPs ultimately may achieve market success through manipulation of product design and marketing to enhance consumer appeal and dependence. PREPs could increase youth initiation or experimentation with tobacco, deter quitting, and help to maintain use among current smokers, thus increasing tobacco-related cancer and other health risk. An effective understanding of the influence of PREP design and marketing on consumer response is urgently required to complement existing research on tobacco harm reduction, and provide an effective public health response to the introduction of new tobacco products. The objectives of this project are to examine the inter-relationships between PREP design and marketing and their effects on consumer response and acceptance, in order to evaluate the potential commercial impact of new and future PREPs. Specifically, the project aims include: 1) identifying and evaluating design characteristics unique to PREPs;2) evaluating the interaction between messaging and product design;and 3) assessing the influence of product design on smoking behavior and exposure. Multiple dimensions of PREP design and marketing will be investigated, with particular focus on behavioral and sensory response to PREPs as compared with conventional cigarettes. The objectives of this project are to examine the inter-relationships between PREP design and marketing and their effects on consumer response and acceptance, in order to evaluate the potential commercial impact of new and future PREPs. Multiple dimensions of PREP design and marketing will be investigated, with particular focus on behavioral and sensory response to PREPs as compared with conventional cigarettes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA125224-03
Application #
7762241
Study Section
Community-Level Health Promotion Study Section (CLHP)
Program Officer
Parascandola, Mark
Project Start
2008-05-06
Project End
2012-01-31
Budget Start
2010-04-06
Budget End
2011-01-31
Support Year
3
Fiscal Year
2010
Total Cost
$669,673
Indirect Cost
Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Alpert, Hillel R; Agaku, Israel T; Connolly, Gregory N (2016) A study of pyrazines in cigarettes and how additives might be used to enhance tobacco addiction. Tob Control 25:444-50
Agaku, Israel T; Vardavas, Constantine I; Ayo-Yusuf, Olalekan A et al. (2014) Gender and racial differences in smoking of long/ultra-long and king size cigarettes among U.S. adult smokers, NHANES 1999-2012. Drug Alcohol Depend 136:28-35
Alpert, Hillel R; Christiani, David C; Orav, E John et al. (2014) Effectiveness of the cigarette ignition propensity standard in preventing unintentional residential fires in Massachusetts. Am J Public Health 104:e56-61
Connolly, Gregory N; Alpert, Hillel R (2014) Has the tobacco industry evaded the FDA's ban on 'Light' cigarette descriptors? Tob Control 23:140-5
Agaku, Israel T; Vardavas, Constantine I; Connolly, Gregory N (2014) Cigarette rod length and its impact on serum cotinine and urinary total NNAL levels, NHANES 2007-2010. Nicotine Tob Res 16:100-7
Agaku, Israel T; Ayo-Yusuf, Olalekan A; Vardavas, Constantine I et al. (2014) Predictors and patterns of cigarette and smokeless tobacco use among adolescents in 32 countries, 2007-2011. J Adolesc Health 54:47-53
Agaku, Israel T; Vardavas, Constantine I; Connolly, Gregory (2013) Proposed cutoff for identifying adult smokeless tobacco users with urinary total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanonol: an aggregated analysis of NHANES 2007-2010 data. Nicotine Tob Res 15:1956-61
Agaku, Israel T; Ayo-Yusuf, Olalekan A; Vardavas, Constantine I et al. (2013) Use of conventional and novel smokeless tobacco products among US adolescents. Pediatrics 132:e578-86
Rees, Vaughan W; Kreslake, Jennifer M; Wayne, Geoffrey Ferris et al. (2012) Role of cigarette sensory cues in modifying puffing topography. Drug Alcohol Depend 124:1-10
June, Kristie M; Norton, Kaila J; Rees, Vaughan W et al. (2012) Influence of measurement setting and home smoking policy on smoking topography. Addict Behav 37:42-6

Showing the most recent 10 out of 16 publications